KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-2.56 Cr | ₹-1.98 Cr | ₹-1.51 Cr | ₹-1.28 Cr | ₹-0.97 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KILITCH DRUGS (INDIA) ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-2.56 Cr |
Mar2023 | ₹-1.98 Cr |
Mar2022 | ₹-1.51 Cr |
Mar2021 | ₹-1.28 Cr |
Mar2020 | ₹-0.97 Cr |
How is Deferred Tax Assets / Liabilities of KILITCH DRUGS (INDIA) Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-2.56 Cr | Negative | |
Mar2023 | ₹-1.98 Cr | Negative | |
Mar2022 | ₹-1.51 Cr | Negative | |
Mar2021 | ₹-1.28 Cr | Negative | |
Mar2020 | ₹-0.97 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹558.8 Cr | 0.6% | 10.2% | -4.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 0.6% |
10.2% |
-4.6% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses